Interleukin-28B acts synergistically with cisplatin to suppress the growth of head and neck squamous cell carcinoma. [electronic resource]
Producer: 20110526Description: 139-48 p. digitalISSN:- 1537-4513
- Animals
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cisplatin -- pharmacology
- Drug Synergism
- Female
- H-2 Antigens -- metabolism
- Head and Neck Neoplasms -- drug therapy
- Interleukins -- pharmacology
- Killer Cells, Natural -- drug effects
- Melanoma, Experimental -- drug therapy
- Mice
- Mice, Inbred C3H
- Neoplasms, Squamous Cell -- drug therapy
- T-Lymphocytes, Cytotoxic -- drug effects
- Xenograft Model Antitumor Assays
- fas Receptor -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.